Stay updated on Gene Therapy XLRP RPGR: Clinical Trial
Sign up to get notified when there's something new on the Gene Therapy XLRP RPGR: Clinical Trial page.

Latest updates to the Gene Therapy XLRP RPGR: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check48 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe study has transitioned from using the AAV2/5 vector to the AAV5-hRKp.RPGR vector for a Phase 1/2 trial assessing safety and efficacy in participants with X-linked Retinitis Pigmentosa, with new results expected to be posted on January 8, 2025.SummaryDifference52%
- Check92 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Gene Therapy XLRP RPGR: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Therapy XLRP RPGR: Clinical Trial page.